This study is currently not recruiting participants.

Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

The purpose of this study is to provide TEZ/IVA to patients who have completed Vertex sponsored clinical trials with TEZ/IVA and are in need of continued treatment, and to patients in critical need who are not able to tolerate approved modulator therapies.

Description

The purpose of this study is to provide TEZ/IVA to patients who have completed Vertex sponsored clinical trials with TEZ/IVA and are in need of continued treatment, and to patients in critical need who are not able to tolerate approved modulator therapies.

Details
Condition cystic fibrosis
Age 100years or below
Clinical Study IdentifierTX8104
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.